Cancer Predictive Score on Breast MRI

Malignity Predictive Factors on Breast MRI With Ultrasound and Mammography Occult Lesions

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04914494

Enrollment

428

Registered

2021-06-04

Start date

2021-01-01

Completion date

2022-09-30

Last updated

2022-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Women imaging, Diagnostic Imaging, Magnetic Resonance Imaging, Breast biopsy, Breast cancer detection, predictive factors, Radiology, Breast lesion diagnosis

Brief summary

Sometimes, breast ultrasound and mammographic can't be diagnose suspsious lesions ( no substratum). So a MRI-guided breast biopsy is perfomed and disclosed ultimately benign lesions. The aim of this retrospective study is to establish a predictive MRI score of occult breast lesions by mammography and ultrasound.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* women aged 18 and more * performed MRI-guided breast biopsy

Exclusion criteria

\- Not MRI-guided breast biopsy

Design outcomes

Primary

Measure	Time frame	Description
Number of participants with MRI characteristics of breast lesions	1 day	MRI characteristics of breast lesions : shape, contours, size, enhancement, perileeal edema, enhancement curve

Secondary

Measure	Time frame	Description
predictive score for the benignity of lesions seen on MRI	1 day	predictive score for the benignity of lesions seen on MRI (and not on mammography and ultrasound) with the criteria which will emerge after multivariate analysis and which will be weighted . score out of 10, with 3 to 5 criteria rated from 0 to 2. 10 would be in favor of benignity and 0 in favor of malignancy.

Countries

France

Outcome results